PMDA drug package insert
ゼオマイン注用50単位
PMDA Prescription drug · 帝人ファーマ株式会社 · package insert Jun 19, 2026
Key facts
| Brand names | ゼオマイン注用50単位, ゼオマイン注用100単位, ゼオマイン注用200単位 |
|---|---|
| Nonproprietary names | インコボツリヌストキシンＡ |
| Companies | 製造販売元（輸入元）／帝人ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | A型ボツリヌス毒素製剤 |
| Therapeutic category codes | 871229, 87129 |
| YJ codes | 1229407D1023, 1229407D2020, 1229407D3026 |
| Approval numbers | 30700AMX00126000, 30700AMX00127000, 30700AMX00128000 |
| Package insert edition | 第6版 |
| Package insert date | Jun 19, 2026 |
| PMDA document key | 470310_1229407D1023_1 |
| PMDA company code | 470310 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: